PMID: 3746811Sep 1, 1986Paper

Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450

Journal of Medicinal Chemistry
R H Böcker, F P Guengerich

Abstract

4-Substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines are important because of their roles as calcium channel blockers. The mixed-function oxidation of 14 4-aryl- and four 4-alkyl-substituted derivatives by human liver microsomes was examined. The major product of enzymatic oxidation of all the 4-aryl compounds was the pyridine derivative containing the 4-aryl group. The 4-alkyl compounds, in contrast, formed a pyridine derivative in which a hydrogen atom was present at the 4-position and the alkyl group was lost; these compounds also inactivated cytochrome P-450 and caused the loss of nifedipine oxidase activity after enzymatic oxidation. All of these reactions were extensively inhibited by an antibody raised to purified human liver nifedipine oxidase cytochrome P-450 (P-450NF), indicating a major role for this enzyme in the oxidation of these compounds. Oxidation of the 4-alkyl compounds led not only to the loss of P-450NF but also to decreases in catalytic activities of cytochrome P-450 isozymes catalyzing other reactions (phenacetin O-deethylation and hexobarbital 3'-hydroxylation). The results indicate that P-450NF (or closely related enzyme forms) is responsible for the oxidation of these nifedipine-rela...Continue Reading

Citations

Jan 1, 1993·Archives of Toxicology·A L MendralaR J Nolan
Jun 1, 1996·Psychopharmacology·D W EylesS M Pond
Mar 3, 1995·Journal of Chromatography. a·Y Tokuma, H Noguchi
Dec 1, 1989·Journal of Molecular Graphics·G G Ferenczy, G M Morris
Apr 8, 2011·The Journal of Biological Chemistry·Raku Shinkyo, F Peter Guengerich
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunV Vijayakumar
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunV Vijayakumar
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunV Vijayakumar
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·B Palakshi ReddyP L Nilantha Lakshman
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Wan-Sin LohS Sarveswari
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Palakshi B ReddyEdward R T Tiekink
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Tara ShahaniS Sarveswari
May 17, 2012·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunShridhar Malladi
Mar 8, 2013·Acta Crystallographica. Section E, Structure Reports Online·Arun M IslorRichard Betz
Jan 11, 2000·Pharmacology & Toxicology·S Beckmann-KnoppU Fuhr
Mar 1, 2012·Organic and Medicinal Chemistry Letters·Om PrakashKamal R Aneja
May 18, 2001·Analytical Biochemistry·K NakamuraF P Guengerich
Jan 11, 2000·Pharmacology & Toxicology·P DamkierK Brøsen
Aug 1, 1993·Journal of Clinical Pharmacology·S K BowlesD J Edwards
Oct 1, 1990·Journal of Clinical Pharmacology·B E BleskeF Morady
Mar 1, 1993·The Journal of Pharmacy and Pharmacology·G W MihalyR A Smallwood
Jun 9, 2001·Mutation Research·F P Guengerich
Jun 1, 1992·Mechanisms of Ageing and Development·C M HuntJ A Wilson
Aug 1, 1994·British Journal of Clinical Pharmacology·T AnderssonD J Birkett
Jun 1, 1994·British Journal of Clinical Pharmacology·T AnderssonD J Birkett
Dec 1, 1993·British Journal of Clinical Pharmacology·T AnderssonD J Birkett
Dec 1, 1993·British Journal of Clinical Pharmacology·S WanwimolrukS Thitiarchakul
Mar 1, 1991·British Journal of Clinical Pharmacology·K FattingerF Follath
Sep 1, 1991·British Journal of Clinical Pharmacology·M G LadonaA Rane
Nov 19, 2015·Future Medicinal Chemistry·Giuseppina IoeleGaetano Ragno
Aug 25, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuka Kawashita, Masahiko Hayashi
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Amit S Kalgutkar, John R Soglia
Jul 7, 2007·Critical Reviews in Toxicology·Yasuhiro Masubuchi, Toshiharu Horie
Jul 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·F P GuengerichT L Macdonald
Dec 11, 2007·International Journal of Pharmaceutics·Elisa FasaniSilvia Gemme
Jul 1, 1988·Biochemical Pharmacology·J H SchellensD D Breimer
Dec 1, 1989·Biochemical Pharmacology·T FunakiD D Breimer
May 20, 2015·Journal of Colloid and Interface Science·Claudio Zapata-UrzúaMarcelo J Kogan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.